Item | Q1 2024 | Q1 2025 | Change |
---|---|---|---|
Revenues | 98.08 | 66.01 | (32.7 %) |
Gross Income | (6.42) | (24.73) | (285.1 %) |
Operating Income | (25.64) | (40.12) | (56.5 %) |
Net Income | (29.70) | (49.52) | (66.8 %) |
Average Shares | 23.52 | 23.52 | - |
Earnings Per Share before unusual items (Riyal) | (1.26) | (2.11) | (66.8 %) |
EPS (Riyal) | (1.26) | (2.11) | (66.8 %) |
Item | Q4 2024 | Q1 2025 | Change |
---|---|---|---|
Revenues | 97.27 | 66.01 | (32.1 %) |
Gross Income | (27.04) | (24.73) | 8.5 % |
Operating Income | (50.18) | (40.12) | 20.0 % |
Net Income | 41.03 | (49.52) | (220.7 %) |
Average Shares | 23.52 | 23.52 | - |
Earnings Per Share before unusual items (Riyal) | (2.63) | (2.11) | 20.1 % |
EPS (Riyal) | 1.74 | (2.11) | (220.7 %) |
The company said the quarterly performance was also impacted by a drop in other income, despite lower cost of sales, selling and distribution expenses, general and administrative costs, and financing charges.
On a sequential basis, Nama Chemicals swung to a loss from a net profit of SAR 41.03 million in Q4 2024.
Total shareholders’ equity, no minority interest, reached SAR 194.63 million as of March 31, 2025, compared to SAR 204.36 million a year earlier.
Accumulated losses by March 31, 2025, reached 43.74 million, representing 18.6% of capital.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: